Literature DB >> 9041327

Maternal immunologic and virologic risk factors for infant human immunodeficiency virus type 1 infection: findings from the Women and Infants Transmission Study.

J Pitt1, D Brambilla, P Reichelderfer, A Landay, K McIntosh, D Burns, G V Hillyer, H Mendez, M G Fowler.   

Abstract

Maternal virus load of human immunodeficiency virus 1 (HIV-1) and maternal immunity are both associated with risk of an infected infant. The interrelationship of these two variables in describing that risk was assessed in a multisite study of 475 mother-infant pairs. Infant infection was associated with low CD4 cell percentage, high CD8, CD8/CD38, and CD8/DR cell percentages, persistently positive HIV-1 cultures, and high HIV-1 titer (P < .001, .001, .005, .006, .001, and .013, respectively). The association of CD4 cell percentage and increased CD8, CD8/CD38, and CD8/DR cell percentages with transmission was restricted to the 42% of women whose HIV-1 cultures were not persistently positive (all P < .001). Women with at least 1 negative culture and high CD4 cell percentage or low CD8 cell percentage were at very low risk (0-4%) of transmitting HIV-1, while those with always positive cultures transmitted at a high rate (18%-27%), regardless of immune status.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041327     DOI: 10.1093/infdis/175.3.567

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable.

Authors:  K S Froebel; G M Raab; C D'Alessandro; M P Armitage; K M MacKenzie; M Struthers; J M Whitelaw; S Yang
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

2.  A review of missed opportunities for prenatal HIV screening in a nationwide sample of health facilities in the Indian Health Service.

Authors:  Brigg Reilley; John T Redd; James Cheek; Scott Giberson
Journal:  J Community Health       Date:  2011-08

Review 3.  Perinatal transmission of HIV and diagnosis of HIV infection in infants: a review.

Authors:  C B Nourse; K M Butler
Journal:  Ir J Med Sci       Date:  1998 Jan-Mar       Impact factor: 1.568

4.  Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection.

Authors:  John S Lambert; Jack Moye; Susan F Plaeger; E Richard Stiehm; James Bethel; Lynne M Mofenson; Bonnie Mathieson; Jonathan Kagan; Howard Rosenblatt; Helene Paxton; Hildie Suter; Alan Landay
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

Review 5.  Advances and failures in preventing perinatal human immunodeficiency virus infection.

Authors:  Ann M Buchanan; Coleen K Cunningham
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

6.  Mutations generated in human immunodeficiency virus type 1 long terminal repeat during vertical transmission correlate with viral gene expression.

Authors:  Roshni Mehta; Vasudha Sundaravaradan; Nafees Ahmad
Journal:  Virology       Date:  2008-03-03       Impact factor: 3.616

7.  Perinatal Transmission of HIV: Recognition and Treatment Interventions.

Authors:  Jaime Deville; Yvonne Bryson
Journal:  Curr Infect Dis Rep       Date:  2001-08       Impact factor: 3.663

8.  Variability of HIV-1 genomes among children and adolescents from São Paulo, Brazil.

Authors:  Sabri Saeed Sanabani; Rodrigo Pessôa; Ana Carolina Soares de Oliveira; Vanessa Pouza Martinez; Maria Teresa Maidana Giret; Regina Célia de Menezes Succi; Karina Carvalho; Claudia Satiko Tomiyama; Douglas F Nixon; Ester Cerdeira Sabino; Esper Georges Kallas
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

9.  German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008.

Authors:  Bernd Buchholz; Matthias Beichert; Ulrich Marcus; Thomas Grubert; Andrea Gingelmaier; Annette Haberl; Brigitte Schmied
Journal:  Eur J Med Res       Date:  2009-11-03       Impact factor: 2.175

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.